Literature DB >> 2112583

Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.

H Heremans1, J Van Damme, C Dillen, R Dijkmans, A Billiau.   

Abstract

The involvement of cytokines in the pathogenesis of a generalized, Shwartzman-like lethal inflammatory response to bacterial lipopolysaccharides (LPS) was studied by testing the ability of cytokines or neutralizing anticytokine antibodies to modify the course of the syndrome. The reaction was elicitable in non-SPF NMRI mice by two consecutive injections of S. marcescens LPS: a first injection in the footpad, followed after 24 h by an intravenous dose; the size and route of the preparatory LPS dose were found to be critical. Treatment with mAbs against IFN-gamma was found to completely prevent the reaction. Treatment with IFN-gamma on the other hand, rendered the mice more sensitive to elicitation of the reaction. In contrast, systemic administration of IFN-alpha/beta exerted a desensitizing effect. The role of endogenous cytokines in the pathogenesis of this generalized Shwartzman reaction was also documented by a study of the cytokine levels in the serum of the mice. In comparisons between mice given lethal and nonlethal induction schedules, a good correlation was found between mortality rates and height of IFN or TNF levels, but no correlation was seen with IL-6 levels. Also, in mice that were protected by anti-IFN-gamma antibody, serum IFN and TNF were undetectable, whereas IL-6 levels were as high as in unprotected mice. These data provide evidence that among the cytokines that govern the inflammatory response to LPS, endogenous IFN-gamma occupies a key position. These findings therefore also open perspectives for clinical application of IFN-gamma antagonists.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112583      PMCID: PMC2187952          DOI: 10.1084/jem.171.6.1853

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide.

Authors:  P Miossec; M Ziff
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  The purification and characterization of rat gamma interferon by use of two monoclonal antibodies.

Authors:  P H van der Meide; M Dubbeld; K Vijverberg; T Kos; H Schellekens
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

3.  Preparation and properties of monoclonal antibodies against murine interferon-beta.

Authors:  I J Bosveld; W P Vonk; R A Hekman; P W van Vliet; P de Jonge; W van Ewijk; J Trapman
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

4.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

5.  Rat monoclonal antibodies. I. Rapid purification from in vitro culture supernatants.

Authors:  H Bazin; L M Xhurdebise; G Burtonboy; A M Lebacq; L De Clercq; F Cormont
Journal:  J Immunol Methods       Date:  1984-02-10       Impact factor: 2.303

6.  Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Authors:  B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Constitutive expression of a murine interferon alpha gene in hamster cells and characterization of its protein product.

Authors:  E C Zwarthoff; I J Bosveld; W P Vonk; J Trapman
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

8.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  Molecular cloning of murine interferon gamma (MuIFN-gamma) cDNA and its expression in heterologous mammalian cells.

Authors:  R Dijkmans; G Volckaert; J Van Damme; M De Ley; A Billiau; P De Somer
Journal:  J Interferon Res       Date:  1985

10.  Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.

Authors:  R D Schreiber; J L Pace; S W Russell; A Altman; D H Katz
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

View more
  56 in total

1.  Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1.

Authors:  T K Held; X Weihua; L Yuan; D V Kalvakolanu; A S Cross
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha.

Authors:  J Theys; S Nuyts; W Landuyt; L Van Mellaert; C Dillen; M Böhringer; P Dürre; P Lambin; J Anné
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

3.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

Authors:  D J Berg; R Kühn; K Rajewsky; W Müller; S Menon; N Davidson; G Grünig; D Rennick
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

4.  In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

Authors:  S H Zuckerman; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

5.  Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.

Authors:  Bernardo S Franklin; Peggy Parroche; Marco Antonio Ataíde; Fanny Lauw; Catherine Ropert; Rosane B de Oliveira; Dhelio Pereira; Mauro Shugiro Tada; Paulo Nogueira; Luiz Hildebrando Pereira da Silva; Harry Bjorkbacka; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

6.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.

Authors:  A C Issekutz; N Lopes
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

8.  Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.

Authors:  M Haak-Frendscho; S A Marsters; S M Chamow; D H Peers; N J Simpson; A Ashkenazi
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock.

Authors:  H Okamura; K Nagata; T Komatsu; T Tanimoto; Y Nukata; F Tanabe; K Akita; K Torigoe; T Okura; S Fukuda
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.

Authors:  M H Wang; H D Flad; W Feist; H Brade; S Kusumoto; E T Rietschel; A J Ulmer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.